Gunther Tulip Vena Cava Filter Set for Femoral Vein Approach Gunther Tulip Vena Cava Filter Set for Jugular Vein Approach Gunther Tulip Vena Cava Filter Set for Femoral and Jugular Vein Approach

FDA-Cleared Indications

• Prevention of pulmonary embolism by placement of a filter in the inferior vena cava.
• Use in patients at risk for venous thromboembolism when protection from pulmonary embolism is clinically indicated.
• Placement through either a femoral vein or jugular vein approach, as applicable to the specific filter set.

Clinical Applications

• IVC filter placement for prevention of pulmonary embolism in selected patients at risk for venous thromboembolism.
• Temporary or retrievable IVC filtration when the treating team expects that protection from pulmonary embolism may no longer be needed later.
• Placement through femoral venous access.
• Placement through internal jugular venous access.
• Use in patients for whom pulmonary embolism protection is indicated and anticoagulation is not appropriate or cannot provide adequate protection, when consistent with the device labeling and clinical judgment.

Reported off-label uses

• Prophylactic IVC filter placement in selected trauma or surgical patients without documented venous thromboembolism, when used outside the labeled indication.
• Use for prevention of embolization from sources other than lower-extremity or pelvic venous thromboembolism, such as selected upper-extremity or right-heart thrombus scenarios.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Practical Considerations

• The set is available for femoral, jugular, or combined femoral-and-jugular approaches; the access route depends on venous anatomy, thrombus location, and procedural planning.
• Placement is generally performed with fluoroscopic or other image guidance through a venous sheath, usually with local anesthesia and moderate sedation when appropriate.
• The filter should be retrieved when protection is no longer clinically needed if retrieval is feasible; prolonged dwell time can increase the risk of filter thrombosis, migration, penetration, fracture, or retrieval difficulty.
• Patients should be assessed for contraindications such as unsuitable IVC anatomy, IVC thrombus that prevents safe deployment, active infection at the access site, or inability to safely access the target vein.
• MRI conditions, maximum compatible vessel and sheath dimensions, filter sizing, and retrieval requirements should be confirmed in the current manufacturer instructions for use before imaging or treatment.